Clinical Trials Directory

Trials / Completed

CompletedNCT01381952

Image Quality and Radiation Dose in Angiography

XRES4 Neuro Claim Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Karolinska University Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

ClarityIQ is a novel X-ray imaging technology, that combines advanced real-time image noise reduction algorithms, with state-of-the-art hardware to reduce patient entrance dose significantly. This is realized by anatomy-specific optimization of the full acquisition chain (grid switch, beam filtering, pulse width, spot size, detector and image processing engine) for every clinical task individually. Furthermore, smaller focal spot sizes and shorter pulses are used, which are known to positively influence image quality . The final effect on the clinical image quality is investigated in this study.

Detailed description

The advent of interventional neuroradiology (INR) has changed the treatment of neurovascular diseases by reducing the procedural invasiveness and the recovery time needed by patients, thus improving clinical outcome. However, INR procedures often require many high-quality digital substraction angiography (DSA) runs and long total fluoroscopy times, which can result in patients being exposed to considerable radiation doses levels. In order to introduce a dose reduction technology the most important aspect is to validate the diagnostic image information. Philips has developed a real-time noise reduction algorithm for DSA in neuroradiology that is capable to reduce the patient entrance dose by 75% without loss of image quality.

Conditions

Interventions

TypeNameDescription
RADIATIONLow dose DSA (75% reduction compared to normal dose) with novel X-ray imaging technology.Digital substraction angiography (DSA) with reduced dose settings (75% reduction expected) in combination with conventional X-ray imaging technology.
RADIATIONNormal dose DSA with conventional X-ray technologyDigital substraction angiography (DSA) with normal dose settings in combination with conventional X-ray imaging technology.

Timeline

Start date
2011-06-01
Primary completion
2011-08-01
Completion
2011-09-01
First posted
2011-06-27
Last updated
2014-05-22
Results posted
2014-05-22

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01381952. Inclusion in this directory is not an endorsement.